The European Lead Factory and COVID-19

20 April 2020

As the world grapples with the COVID-19 crisis, our European Lead Factory (ELF) Partners are working hard to contribute wherever they can to mitigate the impacts of the pandemic. At the same time, the ELF Consortium is looking for ways to contribute collective efforts and assets to help deal with the crisis.

We are striving to maintain normal services as much as possible and are still open to receive screening proposals in all disease areas. COVID-19-related research proposals will be prioritised through a fast-track procedure.

For now, it’s business as usual for the ELF community. We are doing what we can do best, executing early drug discovery projects together with our partners for the European research community,  whilst mapping the impacts of the crisis on the overall project progress.

We wish everyone strength during this difficult and unprecedented time and will continue to provide updates as best we can. Should you have any questions, please do not hesitate to reach out by emailing us at